Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
- DOI
- 10.1172/jci.insight.172728
- Published
- 2023-10-09
- Container
- JCI Insight
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci.insight.172728,
title = {Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2},
author = {Brendan L. Horton and Alicia D. D’Souza and Maria Zagorulya and Chloe V. McCreery and Gita C. Abhiraman and Lora Picton and Allison Sheen and Yash Agarwal and Noor Momin and K. Dane Wittrup and Forest M. White and K. Christopher Garcia and Stefani Spranger},
year = {2023},
journal = {JCI Insight},
doi = {10.1172/jci.insight.172728},
url = {https://doi.org/10.1172/jci.insight.172728}
}RIS
TY - JOUR TI - Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2 AU - Brendan L. Horton AU - Alicia D. D’Souza AU - Maria Zagorulya AU - Chloe V. McCreery AU - Gita C. Abhiraman AU - Lora Picton AU - Allison Sheen AU - Yash Agarwal AU - Noor Momin AU - K. Dane Wittrup AU - Forest M. White AU - K. Christopher Garcia AU - Stefani Spranger PY - 2023 JO - JCI Insight DO - 10.1172/jci.insight.172728 UR - https://doi.org/10.1172/jci.insight.172728 ER -
APA
Horton, B. L., D’Souza, A. D., Zagorulya, M., McCreery, C. V., Abhiraman, G. C., Picton, L., Sheen, A., Agarwal, Y., Momin, N., Wittrup, K. D., White, F. M., Garcia, K. C., & Spranger, S. (2023). Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2. JCI Insight. https://doi.org/10.1172/jci.insight.172728
Source records
- crossref · retrieved 2026-09-26T19:16:29.120Z